Market-Leading Visual Storytellers
We support Biotechs and Pharma
at every stage of the life cycle
PRECLINICAL
DEVELOPMENT
CLINICAL DEVELOPMENT
Phase 1 | Phase 2 | Phase 3
LAUNCH /
POST LAUNCH
BRAND MATURITY
Phase 4
Trusted by Top-20 Pharma and 100+ small and medium Biotechs
High Science. Tech-Enabled
Strategy
Content
Digital + Social
Most Tech-enabled
We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent
-
MoD/MoA animation
and illustration -
Bespoke presentations
-
Field content resources
-
Congress booth programs
-
Websites
-
75% of routine steps are automated using proprietary software and machine learning.
-
The most efficient production pipeline with 3x faster delivery.
-
Data-driven feedback loop optimization for every asset.
-
Live strategy workshops
-
Scientific communications
platform (ScP), lexicon -
Content optimization
and channel planning
-
Microcontent planning
and development:
-
Custom apps
-
Veeva-trained staff
-
Animated data
-
15-second videos
-
Visual digests
All fueled by the most advanced production pipeline in the industry
Precision backed by top voices:
Education & Impact: 500M+ views
and 100+ more
6 animation types
and 20 subtypes for every need — audience, company stage and budget.
INCLUDING TWO UNIQUE
High-End 3D
The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.
UNIQUE SCIENTIFIC-GRADE TYPE
High-End 3D
Coronavirus atomic resolution model
Featured:
UNIQUE SCIENTIFIC-GRADE TYPE
High-end 3D
HIV Atomic Resolution Model
Featured:
Awarded:
UNIQUE SCIENTIFIC-GRADE TYPE
Main 3D
Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.
Main 3D + 2D
The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.
UNIQUE APPROACH
2D Animation
For Nature Journal
A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.
2D Animation:
For HCP and Patient Education
2D Animation:
For HCP and Patient Education
Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos
Deck3D
This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy. The fastest type of 3D animation to produce on the market.
UNIQUE
Pathway3D
Scientific-grade models with the fastest turnaround — delivered in days, not months
A unique combination of scientific-grade molecular simulations that accurately represents real molecular interactions and states, with all the benefits of 2D animation —affordable and fast to produce. Unbeatable quality-to-cost-per-second ratio.
UNIQUE
Character Animation:
For HCP and Patient Education
Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos
Explainer Videos
medical device, procedure, health wearable, and diagnostic companies
Short formats & Chapterized assets
UNIQUE
The Most Tech Enabled
75% of Tasks Automated via Algorithms, Machine Learning, and AI Agents
3D type
High-end 3D
Deck3D
2D type
Pathway3D
+20 subtypes
7-8 weeks
8-10 weeks
4-5 weeks
3-5 weeks
10 days
1-9 weeks
In-House
Studio
STRATEGY
DISCOVERY
DECKS AND INFOGRAPHICS
97% of clients rate working with us 9 or 10/10
Atsena Tx. Investor deck
Type:
Series B deck
Time:
6 weeks
Scope:
IR, scientific flow optimization, design, illustrations, animations
Hookipa (NAS: HOOK) – Corporate Deck
Type:
Corporate deck for public company
Time:
5 weeks
Scope:
Scientific flow optimization, design, illustrations, animations
Jasper Tx (NASDAQ: JSPR) – Corporate Deck
Type:
Corporate deck for public company
Time:
4 weeks
Scope:
Design, illustrations, animations
3D Infographics and Illustrations
Type:
High-end 3D infographics for deck
Time:
1 week
2D Infographics and Illustrations
Type:
2D infographics for deck
Time:
1 week
MoA Illustrations for Decks
WEB & APPS
97% of clients rate working with us 9 or 10/10
APOGEE Tx: Web-site / MoA / Deck
NASDAQ: APGE
Type:
Corporate website for public company
Time:
10 weeks
Scope:
Design, development, illustrations, animations
Enveric Biosciences Web-site
NASDAQ: ENVB
Type:
Corporate website for public company
Time:
9 weeks
Scope:
Design, development, illustrations, animations
Touch Panels and Interactive Decks
For congress support and in field communications
Chapterized Web App with AI assistant
UNIQUE
Augmented Reality
97% of clients rate working with us 9 or 10/10
PosterAR platform
UNIQUE
Augmented Reality App
SCIENTIFIC PLATFORMS LEXICON DEVELOPMENT
-
A medical strategic team that has developed
100+ scientific platforms -
Expertise spanning early pipeline programs
to blockbuster therapies
Much More Than a "Scientific Platform"
01
A cross-functional strategic exercise
to define the clinical value and scientific
rationale of your molecule
02
A clear and compelling story
scalable for all external audiences
03
An internal asset that expedites
approval of external facing assets
Confidential — Not for Public Consumption or Distribution
SCIENTIFIC
PLATFORM
Medical Affairs
Commercial
Regulatory
Clinical Program
IR & Corporate Comm.
Payer/Market Access/HEOR
Scalable from Early to Late-Stage Programs
The overarching story
of your molecule and
the clinical challenge
it solves
NARRATIVE
Breaks down the narrative into 5-6 discrete topics,
such as unmet need, MOA, and clinical
trial results
CONCEPTS
5-8 evidence driven Statements which
support each Concept
STATEMENTS
Hyperlinked and annotated reference that support each statement
EVIDENCE
Identifiable Evidence Gaps Needed to Tell
Full Story of your product
GAPS
Program development:
Confidential — Not for Public Consumption or Distribution
Challenge
Scientific Narratives at Scale
CASE STUDY
We partnered with a Top-10 Pharma companies to effectively scale and manage the development of Scientific Narratives for 30+ oncology assets.
Approach
-
Prioritized molecules to streamline development
Results
Highly organized and dedicated team approach maximized extended client time
that ultimately contributed to timely implementation of narratives at scale.
Confidential — Not for Public Consumption or Distribution
-
Key upcoming data releases
-
Unmet Need, Novel MOA
-
Disease State
-
Development Stage
-
Staggered sets based on aforementioned priorities
to effectively manage large volume/workstreams -
Assigned specific agency teams per set(s)
-
Created succinct narratives for early-stage assets
-
Created comprehensive ScP's for late-stage assets
Scientific Narratives for 30+ Molecules
Intuitive Platform Design
MS Sharepoint or Veeva Vault
Confidential — Not for Public Consumption or Distribution
Appendix
15 years in oncology space
50+
Collaboration with EHA
-
Clonal hematopoiesis (CHIP): mechanisms and consequences
-
The leukemic Bone Marrow niche and pathogenesis of AML
-
BCL2: genetic alteration and role in lymphoid malignancies
-
Mechanisms of action: CAR-T cells
-
Mechanisms of action: Bispecific Abs
-
Mechanisms of action: small molecules inhibitors
-
The role of epigenetic mechanisms in hematological malignancies
-
Techniques: NGS (TIF: PH)
-
Techniques: qPCR (TIF: PH)
-
Techniques: single cell genetics (TIF: pH)
-
Von Willebrand factor structure and defects
-
AI in hematology: AI-based digital morph. analysis
-
Synthetic patients in clinical trials
-
RBCs: Hb linking and releasing O2
Selected Animations:
Have we piqued your interest? Let's chat.
